Evidence map›Paper›PMID 36806498›Full record

ArticleCNS neuroscience & therapeutics2023

Insular cortex stimulation alleviates neuropathic pain via ERK phosphorylation in neurons.

Kyeongmin Kim, Guanghai Nan, Leejeong Kim, Minjee Kwon, Kyung Hee Lee, Myeounghoon Cha, Bae Hwan Lee

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Targeting the insular cortex for neuropathic pain modulation: Insights into synaptic and neuronal mechanisms.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kyeongmin KimDepartment of Physiology, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0001-5771-0773
Guanghai NanDepartment of Physiology, Yonsei University College of Medicine, Seoul, Korea.
Leejeong KimDepartment of Physiology, Yonsei University College of Medicine, Seoul, Korea.
Minjee KwonDepartment of Nursing, Kyungil University, Gyeongsan, Korea.
Kyung Hee LeeDepartment of Dental Hygiene, Division of Health Science, Dongseo University, Busan, Korea.
Myeounghoon ChaDepartment of Physiology, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0002-7993-672X
Bae Hwan LeeDepartment of Physiology, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0003-4719-9021
Yonsei University · KRDongseo University · KRKyungil University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe clinical use of brain stimulation is attractive for patients who have side effects or tolerance. However, studies on insular cortex (IC) stimulation are lacking in neuropathic pain. The present study aimed to investigate the effects of IC stimulation (ICS) on neuropathic pain and to determine how ICS modulates pain.

methodsChanges in pain behaviors were observed following ICS with various parameters in neuropathic rats. Western blotting was performed to assess molecular changes in the expression levels of phosphorylated extracellular signal-regulated kinase (pERK), neurons, astrocytes, and microglia between experimental groups. Immunohistochemistry was performed to investigate the colocalization of pERK with different cell types.

resultsThe most effective pain-relieving effect was induced at 50 Hz-120 μA in single trial of ICS and it maintained 4 days longer after the termination of repetitive ICS. The expression levels of pERK, astrocytes, and microglia were increased in neuropathic rats. However, after ICS, the expression levels of pERK were decreased, and colocalization of pERK and neurons was reduced in layers 2-3 of the IC.

conclusionThese results indicated that ICS attenuated neuropathic pain by the regulation of pERK in neurons located in layers 2-3 of the IC. This preclinical study may enhance the potential use of ICS and identify the therapeutic mechanisms of ICS in neuropathic pain.

Indexed as

Insular CortexNeuralgiaAnimalsExtracellular Signal-Regulated MAP KinasesNeuronsPhosphorylationRatsRats, Sprague-DawleyExtracellular Signal-Regulated MAP Kinasesextracellular signal-regulated kinaseinsular cortexinsular cortex stimulationneuronneuropathic pain

Identifiers

PMID36806498
PMCPMC10173725
OpenAlexW4321372528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.